See on Scoop.itVirology and Bioinformatics from Virology.ca


The results of a phase 2b human clinical trial in HCV infected humans indicate that Miravirsen reduces levels of viral RNA without evidence for viral resistance.


See on www.virology.ws

 

Leave a Reply